Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09
Grant S – The heterogeneity of acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) has led to a multiplicity of treatments, from cytotoxic agents to signal transduction modulators, cell–cycle inhibitors and epigenetic therapies. While some have shown promising initial results, the outlook for AML patients, particularly older and relapsed patients, as well as patients whose cells exhibit certain adverse chromosomal abnormalities or mutant oncoproteins, continues to be grim. Combination chemotherapy using new agents that act at a number of different levels may provide the greatest potential for successful future therapies. A select number of new agents, approaches and combinations are reviewed here.
Related Articles
Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09
Relevance Score: 93%
Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia: The MD Anderson Cancer Center Experience
Journal of Pediatric Hematology/Oncology, 11/30/09
Relevance Score: 92%
Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome
Journal of Clinical Oncology, 12/04/09
Relevance Score: 88%
Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
Supportive Care in Cancer, 12/01/09
Relevance Score: 88%
School of Pharmacy Hopes to Close Clinical Gap for Elderly Blood Disorder
Internet Source, 11/05/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Improvement of Postprandial Endothelial Function after a Single Dose of Exenatide in Individuals with Impaired Glucose Tolerance and Recent Onset Type 2 Diabetes Mellitus
Diabetes Care, 03/22/10
Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/22/10
Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis
Journal of Opioid Management, 03/22/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Polycythemia vera
Internal and Emergency Medicine, 03/22/10
Skin malignancy
InnovAiT, 03/22/10
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/22/10
Article Search
Sponsor
Sponsor


See Latest Articles


